Quintiles' Pike: Innovation is the path to growth

Speaking to local business leaders in Research Triangle Park, Quintiles ($Q) CEO Tom Pike said the life sciences' industry's biggest obstacle is comfort, as long-running biases in medicine can stave off innovation. For Quintiles, the world's largest CRO, growth can come only with continued investments in cutting-edge technology, Pike said. Report